Trial · NCT00664326
Outcomes16
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Objective Tumor Response | From start of treatment of the first participant until database cut-off approximately 13 months later (13May2008 - 31May2009). Assessed every 8 weeks for 6 months, then every 12 weeks | Evaluable for response (Primary analysis population) | Percentage of participants | NUMBER |
| PRIMARY | Tumor Response | From start of treatment of the first participant until database cut-off approximately 13 months later (13May2008 - 31May2009). Assessed every 8 weeks for 6 months, then every 12 weeks | Evaluable for response (Primary analysis population) | Percentage of participants | NUMBER |
| SECONDARY | Disease Control | From start of treatment of the first participant until database cut-off approximately 13 months later (13May2008 - 31May2009). Assessed every 8 weeks for 6 months, then every 12 weeks | Evaluable for response (Primary analysis population) | Percentage of participants | NUMBER |
| SECONDARY | Overall Survival | From start of treatment of the first participant until database cut-off approximately 13 months later (13May2008 - 31May2009). | intention-to-treat (ITT) | Days | MEDIAN |
| SECONDARY | Progression-free Survival (PFS) | From start of treatment of the first participant until database cut-off approximately 13 months later (13May2008 - 31May2009). Assessed every 8 weeks for 6 months, then every 12 weeks | intention-to-treat (ITT) | Days | MEDIAN |
| SECONDARY | Time to Progression (TTP) | From start of treatment of the first participant until database cut-off approximately 13 months later (13May2008 - 31May2009). Assessed every 8 weeks for 6 months, then every 12 weeks | intention-to-treat (ITT) | Days | MEDIAN |
| SECONDARY | Duration of Response | From start of treatment of the first participant until database cut-off approximately 13 months later (13May2008 - 31May2009). Assessed every 8 weeks for 6 months, then every 12 weeks | Only subjects from ITT population with a response of CR or PR were included in this evaluation. | Days | MEDIAN |
| SECONDARY | Duration of Stable Disease (SD) | From start of treatment of the first participant until database cut-off approximately 13 months later (13May2008 - 31May2009). Assessed every 8 weeks for 6 months, then every 12 weeks | Subjects from ITT population who achieved objective response of CR or PR were excluded from this evaluation. | Days | MEDIAN |
| OTHER_PRE_SPECIFIED | Objective Tumor Response (Update) | From start of treatment of the first participant until database cut-off approximately 37 months later (13May2008 - 1Jun2011). Assessed every 8 weeks for 6 months, then every 12 weeks | Evaluable for response (Primary analysis population) | Percentage of participants | NUMBER |
| OTHER_PRE_SPECIFIED | Tumor Response (Update) | From start of treatment of the first participant until database cut-off approximately 37 months later (13May2008 - 1Jun2011). Assessed every 8 weeks for 6 months, then every 12 weeks | Evaluable for response (Primary analysis population) | Percentage of participants | NUMBER |
| OTHER_PRE_SPECIFIED | Disease Control (Update) | From start of treatment of the first participant until database cut-off approximately 37 months later (13May2008 - 1Jun2011). Assessed every 8 weeks for 6 months, then every 12 weeks | Evaluable for response (Primary analysis population) | Percentage of participants | NUMBER |
| OTHER_PRE_SPECIFIED | Overall Survival (Update) | From start of treatment of the first participant until database cut-off approximately 37 months later (13May2008 - 1Jun2011). | intention-to-treat (ITT) | Days | MEDIAN |
| OTHER_PRE_SPECIFIED | Progression-free Survival (Update) | From start of treatment of the first participant until database cut-off approximately 37 months later (13May2008 - 1Jun2011). Assessed every 8 weeks for 6 months, then every 12 weeks | intention-to-treat (ITT) | Days | MEDIAN |
| OTHER_PRE_SPECIFIED | Time to Progression (Update) | From start of treatment of the first participant until database cut-off approximately 37 months later (13May2008 - 1Jun2011). Assessed every 8 weeks for 6 months, then every 12 weeks | intention-to-treat (ITT) | Days | MEDIAN |
| OTHER_PRE_SPECIFIED | Duration of Response (Update) | From start of treatment of the first participant until database cut-off approximately 37 months later (13May2008 - 1Jun2011). Assessed every 8 weeks for 6 months, then every 12 weeks | Only subjects from ITT population with a response of CR or PR were included in this evaluation. | Days | MEDIAN |
| OTHER_PRE_SPECIFIED | Duration of Stable Disease (Update) | From start of treatment of the first participant until database cut-off approximately 37 months later (13May2008 - 1Jun2011). Assessed every 8 weeks for 6 months, then every 12 weeks | Subjects from ITT population who achieved objective response of CR or PR were excluded from this evaluation. | Days | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00664326/outcomes